HIMS Hims & Hers Health Inc

$HIMS “The U.K., Australia, and Germany are each already generating more than $100 million in annualized revenue, with Canada also on track to join this group as well as we scale our generic weight loss offering.”

$HIMS that we are trading about the value after the Novo deal was struck, makes abselutly no sense… in between: -eucalyptus -hims live in australia and germany -testorstone -peptides -eli lly deal -reacceleration in us Should be trading a lot higher than the current Price, very excited for tommorrows ER!💎🙌🎁

$HIMS After the Internet/dot-com boom and AI, the next 10 years will be dominated by longevity and medicine/genetics. I will therefore gradually increase my position and hold it for 5–10 years without touching, with the goal of selling at over 500 per share. In my opinion, HIMS will be one of the leading and dominant players thanks to its business model and strategies. Have a wonderful Sunday, everyone who has invested.

$HIMS ok, i havent been trading a lot long... BUT How is this company trading at these low numbers??? isn't HIMS a frontrunner and the future??? be honest

$HIMS bout to go sub $5B market cap as revenue and subscriptions explode worldwide. Lol ahhaha in 5 years barring end of world from ww3, this will be a 100b min market cap. Buy and hold

$HIMS JUST IN - Jensen Huang was using HIMS new product “Lasting X” which is a 10-hour-long-lasting Viagra-like product while cheating on his wife. BUY BUY BUY

$HIMS ridiculous executive stock compensation. Aggressively declining gross margins. This is a no brainer short.

$HIMS: Hims & Hers Health expands access to Lilly's obesity medicines through its platform, with self-pay pricing starting at $149 monthly.

$HIMS lmao Stocktwits wondering the same thing…. Crazy stupid price action. You’re telling me there has been no positive news to move this stock higher? Clown show

$HIMS I really don't like that the stock price went below the support line. At the same time, they have had all good news and I feel this drop is mostly due to a full market correction rather than HIMS itself. Earnings are next week and I think they will have a lot of good things to say, lots of bad things will be in the past or already prepared for (like their $60 million set aside for lawsuits already factored into last quarters numbers). I expect this stock to rally after earnings and possibly never look back. With all these catalysts (peptides Eli Lilly), it's possible investors looked past the lawsuits and start drooling over the future of this company.

$HIMS Well, they put a link to peptides on the front banner. Let me just put that Karen wig away. Don't know when we'll need that again.

$HIMS Seen this many times.. people think the company has leaked earnings, only for the results to be great and stock reverse. This is funny enough actually giving assurance results will be good.

$HIMS 3bil in yearly sales for this year is the forecast yet its trading 2x revenue... could go down some more but should be a good buy if you're willing to hold long term

$HIMS The Lilly Deals Brings Lower Gross Margins I've been trying to prepare everyone because I see a lot of finfluencers mentioning that they are keeping an eye on gross margins and they want to see it rebound. Yeah, maybe this earnings. But the reality is both the amount of revenue and the COGS associated with selling Lilly products has changed dramatically with this deal. I'll walk through a typical injectable sale below. Pre Deal _______________ Membership: $149 Send patient to Lilly Direct Total Revenue: $149 COGS: 0% Gross Margin: ~100% _____________________ _____________________ Post Deal ______________________ Membership: $149 Medication: $299 Total Revenue: $448 COGS: Wholesale Drug Price: $220 Pharmacy Pick/Pack: 6 Cold-Chain Packaging 5 Overnight Refridgerated 16 Total:$247 Gross Margin: 45% There's 50 more dollars of pre-operating profit with the new deal. Subastantially more revenue on the income statement. But gross margins suffer.

$HIMS wish you guys the best! I fully sold out my position last week after trimming the last 3 months. Went all in on $GOOG @ $276 and sold half today at 292-294. Will sell the rest over $300 and recoup my Hims loss. Good luck guys. Wish yall the best. Last time you’ll see me on hims board - much love 🤝 and hope Hims goes to $50+ for yall

$HIMS One positive thing about upcoming earnings is that we won’t have to worry about 80M worth of legal contingency fees and Eucalyptus acquisition costs dragging down our bottom line like in Q2. Barring any unexpected expenses we should be pretty close to breakeven on a GAAP basis on Monday.

Hims & Hers Health announced a direct partnership with Eli Lilly to distribute its obesity treatments, including injectable Zepbound and newly launched oral Foundayo, through its telehealth platform for cash-pay prices of $299 and $149 per month, respectively. The agreement allows patients to consult licensed providers, obtain prescriptions and receive FDA-approved medications directly through Hims & Hers, eliminating the need to use Lilly's separate direct-pay platform. The deal expands Hims & Hers' branded GLP-1 offering to include products from both major obesity-drug manufacturers, following a similar March 2026 partnership with Novo Nordisk for Wegovy and Ozempic. The move reinforces its strategic shift away from compounded weight-loss drugs toward branded, FDA-approved treatments. Investors are also positioning ahead of Q3 results on November 9, with revenue expected at approximately $892.9M and potential updates on its GLP-1 strategy. $HIMS $LLY $NVO

$HIMS Not sure if you knew this but I heard through a friend of a guy I know that a partnership with Eli Lily is a big deal.

$HIMS YESSSS LFFFGGG HIMSTER FAM. I LOVE YOU ALL. WE HEADED TO MARS ,THE MOON NOT FAR ENOUGH!!!!!! $HIMZ

$HIMS Wont be satisfied until this breaks over 33 minimum, been held down for way too long